NDTP — NDT Pharmaceuticals Balance Sheet
0.000.00%
HealthcareHighly SpeculativeSmall Cap
- $251.21m
- $251.15m
Annual balance sheet for NDT Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2007 December 31st | 2008 December 31st | R2009 December 31st | 2010 December 31st | 2011 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | ARS | ARS | ARS | ARS |
| Standards: | USG | — | — | — | — |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 0.008 | 0.008 | 0.003 | 0.008 | 0.181 |
| Net Total Receivables | 0.101 | 0 | 0.351 | 0.311 | — |
| Prepaid Expenses | |||||
| Total Current Assets | 0.109 | 0.008 | 0.375 | 0.33 | 0.209 |
| Net Property, Plant And Equipment | — | — | — | — | 0.988 |
| Total Assets | 0.109 | 0.008 | 0.375 | 0.33 | 1.2 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.125 | 0.01 | 0.388 | 0.401 | 0 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 0.125 | 0.01 | 0.388 | 0.401 | 0 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | -0.016 | -0.002 | -0.014 | -0.071 | 1.2 |
| Total Liabilities & Shareholders' Equity | 0.109 | 0.008 | 0.375 | 0.33 | 1.2 |
| Total Common Shares Outstanding |